tiprankstipranks
BeiGene (BGNE)
NASDAQ:BGNE
Holding BGNE?
Track your performance easily

BeiGene (BGNE) Stock Investors

725 Followers
Based on 769,654 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold BGNE
On average, investors allocate 2.62% of their portfolios to BGNE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 769,654 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding BGNE

4.3%
Last 7
Days
3.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding BGNE, out of 769,654 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

BGNE Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.00%
$201.31
Increased
1.85%
$160.94
Based on the activity of 14,714 investors who made their portfolios public
The table shows changes in BGNE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

BGNE Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
BlackRock
4.64%
-1.85%
+5.49%
160.53B
Financial
Carnival
6.35%
-2.06%
+7.14%
31.19B
Consumer Cyclical
Applied Materials
3.98%
-1.69%
+1.68%
144.17B
Technology
Zscaler
3.66%
-3.30%
-4.58%
32.17B
Technology
JD
5.01%
-1.71%
+1.77%
56.70B
Consumer Cyclical
Block
4.40%
-3.49%
+0.66%
57.18B
Technology
Arista Networks
4.31%
-1.44%
+3.59%
128.02B
Technology
Enphase Energy
4.57%
-2.82%
-2.67%
8.96B
Technology
Bristol-Myers Squibb
3.56%
-2.56%
-2.61%
119.40B
Healthcare
DraftKings
5.43%
-3.48%
-1.85%
37.95B
Consumer Cyclical
Based on the activity of 769,654 active portfolios
Open your Smart Portfolio

BGNE Investor Analysis

BGNE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.8%
of BGNE holders
are under 35
Average Segment Performance
Average P/E Ratio29.30
Beta10.71
Dividend Yield195.35%
BGNE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
46.8%
of BGNE holders
are between 35–55
Average Segment Performance
Average P/E Ratio26.56
Beta20.58
Dividend Yield89.27%
BGNE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
45.5%
of BGNE holders
are over 55
Average Segment Performance
Average P/E Ratio25.04
Beta9.37
Dividend Yield151.42%
Overview of age group and performance of BGNE stock investors
See who invests in BGNE according to age group and performance.

FAQ

How many retail Investors hold BGNE?
<0.1% of TipRanks' retail investors hold BGNE in their portfolios.
    What is BGNE Investor Sentiment?
    BGNE’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of BGNE in the last 7 days?
      ▼ 4.3% of TipRanks' retail investors changed their holding of BGNE in the last 7 days.
        What percentage of retail investors changed their holding of BGNE in the last 30 days?
        ▼ 3.1% of TipRanks' retail investors changed their holding of BGNE in the last 30 days.
          What is the average age of retail investors who hold BGNE?
          The average age of BGNE Holders is between 35–55.
            What other stocks have BGNE investors also bought?
            BGNE Investors also bought BLK, CCL, AMAT, ZS, JD, SQ, ANET, ENPH, BMY, DKNG.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              CRMDCormedix
              GERNGeron
              IONSIonis Pharmaceuticals
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis